Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2007-07-17
2007-07-17
Wehbe, Anne M. (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
C800S021000, C800S025000, C426S580000
Reexamination Certificate
active
10663454
ABSTRACT:
The present invention provides transgenic, non-human animals that include a transgene that encodes a fatty acid desaturase, e.g., stearoyl-CoA desaturase, and methods for producing such animals. The invention further provides an expression cassette that includes a coding region for a desaturase such as stearoyl-CoA desaturase, operably linked to a heterologous, tissue-specific animal cell promoter. The invention further provides methods of producing a food product, such as milk, meat, or eggs, using a subject transgenic non-human animal, as well as food products harvested from a subject transgenic non-human animal.
REFERENCES:
patent: 5667839 (1997-09-01), Berg
patent: 5959171 (1999-09-01), Hyttinen et al.
patent: 5968809 (1999-10-01), Knutzon et al.
patent: 6333353 (2001-12-01), Saebo et al.
patent: 6410761 (2002-06-01), Saebo et al.
patent: 6432469 (2002-08-01), Rummereit
patent: 6432684 (2002-08-01), Mukerji et al.
Wilmut et al. “Somatic cell nuclear transfer,” Nature 419:583-586, 2002.
Humpherys et al. “Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei,” PNAS 99(20): 12889-12894.
Ward et al. “The ovine stearyl-coA desaturase gene: Cloning and determination of gene number within the ovine gnome,” Biochemical Society Transactions 25(S673):145.
Miyake et al. “Increased production of Apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7a-hydroxylase,” J Biol Chem 276(26):23301,23311, 2001.
Hammer et al “Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders,” Cell 63(5):1099-112, 1990.
Cameron et al. “Recent advances in transgenic technology,” Molecular Biotechnology 7:253-265, 1997.
Cowan et al. “Targeting gene expression to endothelium in transgenic animals: a comparison of the human ICAM-2, PECAM-1 and endoglin promoters,” 10:223-231, 2003.
Kappel et al. “Regulating gene expression in transgenic animals,” Current Opinion in Biotechnology 3:548-553, 1992.
Mench JA “Ethics, animal welfare and transgenic farm animals,” in Transgenic Animals in Agriculture, pp. 251-268, CABI Publishing, New York, NY, 1999.
Mihara, 1990, J. Biochem, 108: 1022-1029.
Kim et al., 2000, Journal of Lipid Research, 1310-1316.
Watts and Browse, 2000, Biochemical and Biophysical Research Communications, 272: 263-269.
Minchin et al., 2001, J. of Pharm. and Exp. Therap., 296: 1006-1012.
Smith, 2004, Int. J. Med. Sci., 1: 76-91.
Page et al., 1995, Transgenic Research, 4: 12-17.
Oback and Wells, 2002, Cloning and Stem Cells, 4: 147-168.
Campbell et al., 2005, Reprod. Dom. Anim.,40: 256-268.
Tian et al. 2003, Reprod. Bio. & Endocrin., 98: 1-7.
Li et al., 2003, Reprod. Bio. & Endocrin., 84: 1-6.
McEvoy et al., 2003, Reprod. Supp., 61:167-182.
Vogel, 2003, Science, 300: 225-227.
Simerly et al., 2003, Science, 300: 297.
Pereia et al., 2003, Prostaglandins, Leukotrienes, and Essential Fatty Acids, 68, 97-106.
Shanklin et al., 1994, Biochemistry, 33: 12787-12794.
Hammer et al., 1986, J. Anim. Sci., 63: 269-278.
Ward et al, 1997, Biochemical Society Transactions, 25: S673, abstract No. 145.
Medran et al., 2000, Pflugers Archive European Journal of Physiology, 439: R24.
Maga and Murray (1995)Bio/Technol. 13:1452-1457.
Strittmatter et al. (1974)Proc. Natl. Acad. Sci. USA71:4565-4569.
van Berkel et al. (2002)Nat. Biotechnol,20: 484-487.
Horton, J.D. et al., “Activation of Cholesterol Synthesis in Preference to Fatty Acid Synthesis in Livers and Adipose Tissue of Transgenic Mice Overexpressing Sterol Regulatory Element-Binding Protein-2” Journal of Clinical Investigation, Jun. 1998, vol. 101, No. 11, pp. 2331-2339.
Shimano, H. et al., “Isoform 1c of Sterol Regulatory Element Binding Protein in Less Active Than Isoform 1a in Livers of Transgenic Mice and in Cultured Cells. Journal of Clinical Investigation” Mar. 1997, vol. 99, No. 4, pp. 846-854.
Shimano, H. et al., “Overproduction of Cholesterol and Fatty Acids Causes Massive Liver Enlargement in Transgenic Mice Expressing Truncated SREBP-1a” Journal of Clinical Investigation. Oct. 1996, vol. 98, No. 7 pp. 1575-1584.
Miyake, J.H. et al. “Increased Production of Apoliprotein B-Containing Lipoproteins in the Absence of Hyperlipidema in Transgenic Mice Expressing Cholesterol 7-Alpha-Hydroxylase. Journal of Biological Chemistry” Jun. 29, 2001, vol. 276, No. 26, pp. 23304-23311.
Shimomura, I et al., “Nuclear Sterol Regulatory Element-Binding Proteins Active Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver” Journal of Biological Chemistry. Dec. 25, 2998, vol. 273, No. 63, pp. 35299-35306.
Brembeck, F.H. et al., “The Keratin 19 Promoter is Potent for Cell-Specific Targeting of Genes in Transgenic Mice” Gastroenterology. 2001, vol. 120, pp. 1720-1728.
Aihara H., et al., “The TB3 Gene Promoter Directs Intestinal Epithelial Cell-Specific Expression in Transgenic Mice” FEBS Letters. 1999, vol. 463, pp. 185-188.
Maga Elizabeth A.
Murray James D.
Borden Paula A.
Bozicevic Field & Francis LLP
Hama Joanne
The Regents of the University of California
Wehbe Anne M.
LandOfFree
Stearoyl CoA desaturase transgenic non-human animals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stearoyl CoA desaturase transgenic non-human animals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stearoyl CoA desaturase transgenic non-human animals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3730404